Rivaroxaban

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on February 8, 2020.

Return to the list of Patented Medicine Litigation page.





Rivaroxaban

XARELTO – Bayer Inc. (NOC Search)

Patents:

  • 2396561: SANDOZ, APOTEX, TEVA
  • 2451258: TEVA
  • 2547113: TARO PHARMACEUTICALS, SANDOZ, TEVA, APOTEX, SANDOZ, TARO PHARMACEUTICALS, APOTEX, TEVA, APOTEX, TEVA, SANDOZ, TARO PHARMACEUTICALS, ACCORD HEALTHCARE
  • 2624310: ACCORD HEALTHCARE, SANDOZ, TARO PHARMACEUTICALS, TEVA, APOTEX, SANDOZ, TARO PHARMACEUTICALS, APOTEX, TEVA, TARO PHARMACEUTICALS, SANDOZ, TEVA, APOTEX
  • 2634310: TEVA
  • 2823159: SANDOZ, TARO PHARMACEUTICALS, APOTEX, TEVA, TARO PHARMACEUTICALS, SANDOZ, TEVA, APOTEX, TARO PHARMACEUTICALS, SANDOZ, ACCORD HEALTHCARE, TEVA, APOTEX

Unknown/Other

ACCORD HEALTHCARE

APOTEX

SANDOZ

SANDOZ, TARO PHARMACEUTICALS, APOTEX, TEVA

TARO PHARMACEUTICALS

TARO PHARMACEUTICALS, SANDOZ, TEVA, APOTEX

TEVA

TEVA, APOTEX, TARO PHARMACEUTICALS, SANDOZ


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property